Tag: GlaxoSmithKline

All

Five RSV Articles for the Week

FDA panel favors approval for two RSV vaccines, 'Tripledemic' hits US households, and a monoclonal antibody may be ready for next season—here are five RSV stories you should check out this week.

Positive Phase III Data for GSK RSV Vaccine Candidate
Monoclonal Antibody Sotrovimab No Longer Authorized in Northeastern US
GSK and Medicago’s Plant-based Covifenz Vaccine Approved in Canada
Sanofi-GSK Vaccine 100% Effective in Preventing Against Severe COVID-19, Hospitalizations
Philip Morris’ Battle to Buy Asthma Drugmaker Vectura
GSK Recalls Children’s Cough Syrup
GSK Says There’s No Link Between Pandemic H1N1 Flu Vaccine and Sleep Disorder

All

GSK Grants Will Support ATS COVID-19 Crisis Fund

GlaxoSmithKline has issued two grants totaling $380,000 to the American Thoracic Society's COVID-19 Crisis Fund.

FDA Questions Efficacy of GSK’s Nucala for COPD
Childhood Asthma: Arnuity Ellipta Approved for Kids 5-and-older
Triple Therapy More Effective for COPD than Dual Inhalers?
COPD Triple-combo Therapy Gets Expanded Indication
GlaxoSmithKline Lung Drug Anoro Approved In Europe
Anoro Ellipta Available In US For Treatment Of COPD

All

GSK Completes Enrollment for Landmark COPD-CVD Study

GlaxoSmithKline and Theravance have completed enrollment of 16,000 patients for SUMMIT, a study to determine the impact of GSK's Breo Ellipta on all cause mortality amongst patients with moderate COPD and cardiovascular disease.

First Non-inhaled Treatment for Severe Asthma Shows Promise
Four Respiratory Drugs on Pathway to CE Approval

Tag: GlaxoSmithKline

All

All

All

Sorry, No Posts Found